Venture capital investor Brightlands Venture Partners (BVP) is launching a new fund focused on startups and scaleups in sustainability and health. The fund bears the name Brightlands Venture Partners Fund IV and has an initial closing of €45 million. With this, investments will be made in circular chemistry, regenerative medicine and agrofood.
About Brightlands Venture Partners
Brightlands Venture Partners is the fund manager of BVP Fund IV and is a so-called ecosystem investor. It invests in innovative companies that can benefit from and contribute to the ecosystem of the Brightlands campuses in the south of the Netherlands. Funds under management are Chemelot Ventures, Brightlands Agrifood Fund and Limburg Ventures. BVP Fund IV focuses on innovations in sustainability and health and is the successor fund to Chemelot Ventures, which was established in 2014.
Brightlands Venture Partners has in recent years participated in about 40 companies that make important contributions in the field of climate and health with their innovative products and processes. The money for the new fund comes from four existing funders: DSM Netherlands, province Limburg, LIOF and Rabo Corporate Investments. In addition, the Rijksdienst voor Ondernemend Nederland (RVO) is contributing €10 million for investments in circular chemistry.
With the new fund, Brightlands Venture Partners will invest in startups and scaleups in the Netherlands, Belgium and North Rhine-Westphalia that can benefit from and contribute to the Brightlands ecosystem. Casper Bruens, Managing Partner of Brightlands Venture Partners: "This first closing provides a solid basis; the fund is open to additional professional investors who want to generate more impact together with us. Brightlands means circular chemistry, regenerative medicine, agro-food and related digital technologies, precisely the areas where such an impact is especially needed."